The present Invention relates to substituted Heterocyclic Condensed formula (i) where a and e are n or C, B is co, N or g is n or CH cr30 where at least one of a, B, e or g is n R30 is H OR N - (cr11r12 R32) R11 and R12 are H or c1-c6 alkyl n is 0, 1, 2 or 3 R32 is c1-c6 alkyl, cicloalquil Or C3, C8, among others, A1A, r1b, r1c, 2a, R2B and R2c are h, F,Among others and Z is n or CH, is a Link, or, among others R3 is link or (cr7r7\u00b4) P p is 0, 1, 2, 3 or 4 R7 and r7\u00b4son H or c1-c6 alkyl R4 is c1-c6 alkyl, cycloalkyl C3, C8, among others.Preferred compounds are (3R) - 3 - [[4 - (Cyclopropylmethoxy) - 3-pyridyl] oxy] - 1 - (2 - 2-cyclopropyl-1 - [1,2,4] triazolo [1,5-a] pyridin-3 (IL - 6) pyrrolidin-2-one (3R) - 3 - [[4 - (Cyclopropylmethoxy) - 3-pyridyl] oxy] - 1 - ([1,2,4] triazolo [1,5-a] pyridin-3 (IL - 6) pyrrolidin-2-one among others. It also relates to a Pharmaceutical composition.These compounds modulate receptor GPR19 being useful in the Prevention and \/ or treatment of Diabetes and Related DisordersLa presente invencion se refiere a heterociclicos condensados sustituidos de formula (I) donde: A y E son N o C B es CO, N o CH G es N o CR30 en donde al menos uno de A, B, E o G es N R30 es H o (CR11R12)n-R32 R11 y R12 son H o alquilo C1-C6 n es 0, 1, 2 o 3 R32 es alquilo C1-C6, cicloalquilo C3-C8, entre otros R1a, R1b, R1c, R2a, R2b y R2c son H, F, entre otros Y es N o CH Z es un enlace, O, entre otros R3 es enlace o (CR7R7´)p p es 0, 1, 2, 3 o 4 R7 y R7´son H o alquilo C1-C6 R4 es alquilo C1-C6, cicloalquilo C3-C8, entre otros. Son compuestos preferidos: (3R)-3-[[6-(Ciclopropilmetoxi)-3-piridil]oxi]-1-(2-ciclopropil-[1,2,4]triazolo[1,5-a]piridin-6-il)pirrolidin-2-ona (3R)-3-[[6-(Ciclopropilmetoxi)-3-piridil]oxi]-1-([1,2,4]triazolo[1,5-a]piridin-6-il)pirrolidin-2-ona entre otros. Tambien se refiere a una composicion farmaceutica. Dichos compuestos modulan el receptor GPR19 siendo utiles en la prevencion y/o tratamiento de diabetes o trastornos relacio
